Pterosin B

CAT:
804-HY-N1570-01
Size:
5 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Pterosin B - image 1

Pterosin B

  • Description:

    Pterosin B is an orally active indanone. Pterosin B can be obtained from Pteridium aquilinum. Pterosin B is a Sik3 signaling inhibitor. Pterosin B inhibits Klf5 expression and reduces β-amyloid deposition. Pterosin B prevents chondrocyte hypertrophy and osteoarthritis in mice. Pterosin B inhibits cardiomyocyte hypertrophy, improves cognitive impairment, and lowers blood glucose. Pterosin B can be used in research on arthritis, Alzheimer's disease, pathological cardiac hypertrophy and diabetes[1][2][3][4][5].
  • UNSPSC:

    12352005
  • Hazard Statement:

    H302, H315, H319, H335
  • Target:

    Amyloid-β; KLF; Salt-inducible Kinase (SIK)
  • Type:

    Natural Products
  • Related Pathways:

    Immunology/Inflammation; MAPK/ERK Pathway; Neuronal Signaling
  • Applications:

    COVID-19-immunoregulation
  • Field of Research:

    Endocrinology; Metabolic Disease; Inflammation/Immunology; Neurological Disease; Cardiovascular Disease
  • Assay Protocol:

    https://www.medchemexpress.com/pterosin-b.html
  • Purity:

    99.98
  • Solubility:

    DMSO : 250 mg/mL (ultrasonic)
  • Smiles:

    O=C1[C@H] (C) CC2=C1C (C) =C (CCO) C (C) =C2
  • Molecular Formula:

    C14H18O2
  • Molecular Weight:

    218.30
  • Precautions:

    H302, H315, H319, H335
  • References & Citations:

    [1]Hannah R.Dexter, et al. A concise stereoselective synthesis of pterosin B. Tetrahedron Letters, Volume 59, Issue 49, 5 December 2018, Pages 4323-4325.|[2]Yahara Y, et al. Pterosin B prevents chondrocyte hypertrophy and osteoarthritis in mice by inhibiting Sik3. Nat Commun. 2016 Mar 24;7:10959.|[3]Lee C Y, et al. Novel therapeutic effects of pterosin B on Ang II-induced cardiomyocyte hypertrophy. Molecules, 2020, 25 (22) : 5279.|[4]Zhang Y, et al. Pterosin B improves cognitive dysfunction by promoting microglia M1/M2 polarization through inhibiting Klf5/Parp14 pathway. Phytomedicine. 2024 Dec;135:156152.|[5]Itoh Y. Pterosin B, ingredient in Pteridium aquilinum, regulates hepatic gluconeogenesis via SIK3-dependent and independent mechanisms. 2017.
  • Shipping Conditions:

    Room Temperature
  • Storage Conditions:

    -20°C, 3 years; 4°C, 2 years (Powder)
  • Scientific Category:

    Natural Products
  • Clinical Information:

    No Development Reported
  • Isoform:

    SIK3
  • CAS Number:

    34175-96-7